CORAL GABLES, FL / ACCESSWIRE / June 25, 2015 / Many companies and their publicly traded stock have been hurt this year by the stronger dollar. Even gold prices have shuttered as the US currency has gained value in the exchange markets. Retail, energy, the list goes on and on as far as which sectors have been hit the worst. But it hasn’t been all doom and gloom for the entire market. Higher volatility trading like that involved with penny stocks has not felt the brunt of this event. In fact many of these companies and their stocks have seen an increase in trading volume as well as price, over the better part of the last two months. Enviro-Serv Inc (PINKSHEETS: EVSV), US Precious Metals (OTCQB: USPR), and TapImmune, Inc (OTCQB: TPIV) have seen positive price movement and increased share volume during the late spring and early summer season.

Envir-Serv targets highly profitable small service companies in the commercial and residential property maintenance industry. Through its subsidiary Xterminate the company has begun to enter the final stages of closing on a franchise deal with Pestmaster Services for control of the Tampa area operations. In working with the franchise, Enviro-Serv has the opportunity to secure much larger contracts including those with the government because Pestmaster Services is a national Franchisor and a dominant player in the Governmental contracts sector for pest control. There are 21,000 pest control companies in the U.S. and only 70 are approved to bid on Government contracts. Based on this data and several key announcements, EVSV shares have rallied from lows of $0.0002 to highs of $0.0015 in recent weeks.

US Precious Metals has also seen an increase in trading activity most notably over the last few days of trading. The company updated the public on its current drilling program, which is underway on its property in Mexico. Based on finding significant mineralization in each of the cores that have been drilled, these are now being assayed by an independent lab. For mining companies, this tends to be one of the final steps in determining if or when operations can begin. Speculation has sparked more attention on the stock as volume skyrocketed to over 4 million shares traded during the first half of the week. Currently trending in a price channel between 0.14 and 0.16, shares of USPR have seen prices as high as $0.20 this month.

The biotech space is hot right now and TapImmune has found a similar trend. What looks to have started in May, the run that this stock has been on has lasted the better part of the last two months. The stock saw lows of $0.165 on May 6 and since then the stock has rallied to highs of $1.71. This week the Company reported the completion of data analysis from patients treated in a Phase I clinical trial. Dr. Glynn Wilson, TapImmune’s CEO stated “We are excited by the Phase I results of our HER2/neu vaccine trial. The potential to treat ~85% of breast cancer patients with this HER2/neu therapeutic approach is significant. The successful completion of this HER2/neu vaccine Phase I study and the robust immune responses detected provides TapImmune with a second Phase II clinical candidate and an expanded clinical pipeline for the treatment of breast and ovarian cancer. It also further validates the technology and the approach developed at Mayo Clinic by Professor Keith Knutson.”

ABOUT US:

www.DailyStockReporter.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals www.DailyStockReporter.com is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading Penny Stocks. You can subscribe to the www.DailyStockReporter.com newsletter and start receiving daily alerts. To subscribe by phone and receive messages directly to a mobile phone, text the phrase “StockAlerts” to 63566.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements.

EGM FIRM INC which owns www.DailyStockReporter.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release.

EGM FIRM INC, which owns www.DailyStockReporter.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice.

EGM FIRM INC which owns www.DailyStockReporter.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.

CONTACT:

Company: EGM FIRM INC.
Contact Email: adam@egmfirm.com

SOURCE: DailyStockReporter.com

ReleaseID: 430150

NEW
YORK, NY / ACCESSWIRE / June 25, 2015 / SeeThruEquity, a leading
independent equity research and corporate access firm focused on smallcap and
microcap public companies, today announced it has initiated coverage of
MetaStat, Inc. (OTCQB: MTST) with a price target of $1.23.

The report is available here: MTST
Initiation Report. SeeThruEquity is an approved equity research
contributor on Thomson First Call, Capital IQ, FactSet, and Zack’s. The report
will be available on these platforms. We also contribute our estimates to
Thomson Estimates, the leading estimates platform on Wall Street.

Based in Boston, MA, is a
development-stage life sciences company focused on novel diagnostics offerings
for the early identification and treatment of systematic metastasis –
cancer that spreads from a primary tumor through the bloodstream into other
areas of the body. Led by an experienced management team and Board of
Directors, MetaStat is developing an innovative lineup of proprietary diagnostics
tests, currently including MetaSite
Breast(TM) and
MenaCalc(TM), which utilize epigenetic markers to
predict the risk of distant metastasis. The company is focusing on breast,
prostate, lung and colorectal cancers, where systematic metastasis is
responsible for 90% of all solid tumor cancer related deaths. We see several
catalysts ahead over the next 12-18 months for MetaStat.

The company is led by new CEO Douglas
Hamilton, who was promoted from CFO in June. Mr. Hamilton brings a wealth of
experience to MetaStat, having served previously as CFO of SEA Medical Systems
and COO and CFO of Javelin Pharmaceuticals, in addition to operational roles at
Amgen, Pfizer, PolaRx, and Pharmacia Biotech (GE Life Sciences). We note
Javelin was acquired by Hospira, where Hamilton led the company to
commercialization and through its successful national markets
up-listing.

“We see nice momentum at MetaStat.
The company has a new CEO and is developing an innovative lineup of proprietary
diagnostic tests. It aims to bring to market its first commercial products,
targeting breast cancer, during 2016 based on CLIA and Massachusetts state
certification,” stated Ajay Tandon, CEO of SeeThruEquity. “We are
initiating coverage with a 12-month price target of $1.23 per
share.”

Additional highlights from the report
are as follows:

Novel technology provides
superior diagnostics

MetaStat’s proprietary technology
results from over 15 years of collaboration with leading scientific and
academic institutions including the Albert Einstein School of Medicine and MIT.
At the core of the technology is the identification of a common pathway for the
development of metastatic disease in solid epithelial-based tumors. The
company’s two prospective diagnostics offerings, the MetaSite Breast(TM) cancer
test and MenaCalc™ diagnostic platform, provide actionable
information regarding the metastatic potential of a patient’s tumor. Physicians
can use the diagnostics to individualize therapies and to help guide treatment
strategies including determining the utility of prophylactic chemotherapy or
surgery. We expect MetaStat to commercialize its breast cancer diagnostic
during 2016E, and believe it will launch MenaCalc™ diagnostic
platform for other solid tumors including colon, lung, and colorectal cancers,
beginning in 2017E.

Large market potential
with applications in several cancers

MetaStat’s innovative diagnostics
offerings target a large market opportunity with significant potential. The
market for global molecular diagnostic testing is estimated to be $7.5Bn.
MetaStat’s initial products, MetaSite Breast(TM), and the MenaCalc Breast(TM),
will target breast cancer. This represents a substantive opportunity for the
company, as breast cancer is the second leading cause of cancer death in women.
According to the American Cancer Society, there will be
234,190 new cases of invasive breast cancer each year in the United States, and
over 40,000 deaths due to breast cancer. MetaStat’s diagnostic offerings
address approximately 80% of newly diagnosed early stage invasive breast cancer
cases including all molecular subtypes, which represents a $271mn market opportunity
for the company.

Following the launch of its breast
cancer diagnostic offering, MetaStat has plans to commercialize MenaCalc(TM)
for other indications. MenaCalc(TM) is a diagnostics platform the company
believes will be broadly applicable to most epithelial-based tumors
(carcinomas), which make up approximately 85% of all cancers. With 1.7mn people
diagnosed with cancer each year in the United States, over time MetaStat’s
potential target patient population in the U.S. could approach 1.4mn per year.
Initially we expect the company to follow the breast cancer diagnostic offering
with MenaCalc(TM) platforms for prostate cancer, lung cancer, and colon cancer.
In aggregate, the four indications represent an addressable market of 559,712
cases, or $627mn, according to the company.

Initiate coverage with a
price target of $1.23

Our analysis of MetaStat indicates a
fair value estimate of $1.23 per share implying an upside of 300.0% from the
recent price of $0.31. We view the company as an intriguing high risk / high
reward investment opportunity in the cancer diagnostics industry.

Please review important disclosures on
our website at www.seethruequity.com.

About MetaStat,
Inc.

MetaStat, Inc. (MTST) is a molecular diagnostic
company that develops and commercializes diagnostic tests for early and
reliable prediction of systemic metastasis, the process by which cancer spreads
from a primary tumor through the bloodstream to other areas of the body.
MetaStat is focused on breast, prostate, lung and colorectal cancers, where
systemic metastasis is responsible for approximately 90% of all deaths. The
company’s epigenetic-based diagnostic platform technology is based on the
identification and understanding of the pivotal role of the mena protein and
its isoforms, a common pathway for the development of systemic metastatic
disease in epithelial-based solid tumors. Both the MetaSite(TM) and MenaCalc(TM)
assays are designed to accurately stratify patients based on their individual
risk of metastasis and to provide physicians with clinically actionable
information to better “customize” cancer treatment. MetaStat’s
testing platform aims to improve treatment planning decisions by positively
identifying patients with a high-risk of metastasis who need aggressive therapy
and by sparing patients with a low-risk of metastasis from the harmful side
effects and expense of chemotherapy. The company is based in Boston.

About
SeeThruEquity

SeeThruEquity is an equity research and
corporate access firm focused on companies with less than $1 billion in market
capitalization. The research is not paid for and is unbiased. We do not conduct
any investment banking or commission based business. We are approved to
contribute our research to Thomson One Analytics (First Call), Capital IQ,
FactSet, Zacks, and distribute our research to our database of opt-in
investors. We also contribute our estimates to Thomson Estimates, the leading
estimates platform on Wall Street.

For more information visit www.seethruequity.com.

Contact:

Ajay Tandon
SeeThruEquity
info@seethruequity.com

SOURCE:
SeeThruEquity

ReleaseID: 430148

With this Addition, the Company Now has 17 Grocery Distribution Centers; Expects Grocery Store Venue Revenue in 2015 to Grow 70-90% vs. 2014

INDIANAPOLIS, IN / ACCESSWIRE / June 25, 2015 / Noble Roman’s, Inc. (OTCQB: NROM), the Indianapolis based franchisor and licensor of Noble Roman’s Pizza and Tuscano’s Italian Style Subs, today announced that over the past two months, the company has provided inventory to seven new grocery distribution centers, representing approximately 1,200 grocery stores in six states. The company has now stocked a total of 17 grocery store distribution centers across the country.

Paul Mobley, Chairman and Chief Financial Officer, commented, “Interest in our grocery store venue continues to expand, and we are building the network to enable us to take advantage of this opportunity by adding distribution centers, which gives us new potential customers for further expansion. Our policy is to count a distribution center as part of our network only after initial inventory orders are delivered. We are encouraged by this progress, and expect to add seven to 10 additional distribution centers by the end of August.”

The Company will be demonstrating its take-n-bake products at the national convention of one of the largest grocery distribution chains in August to representatives from thousands of grocery stores around the country. The previously announced two larger grocery store chains that signed agreements in late 2014 began opening the company’s take-n-bake concept in the second quarter, and are expected to continue to open additional locations this year.

As a result of this progress in the Grocery Store Venue, management currently expects 2015 revenue for this portion of the business to grow 70-90% compared to 2014, representing full-year revenue of $2.5 million to $2.8 million. Overall, management expects full-year 2015 revenue to be between $9.3 million and $9.9 million, representing an increase of approximately 20% compared to 2014.

The company continues to focus on growth in three primary venues: non-traditional franchises and licenses other than grocery stores (“host premise” venue), the sale of take-n-bake pizzas through grocery deli departments and stand-alone take-n-bake franchised locations.

About Noble Roman’s

Noble Roman’s, Inc. sells and services franchises and licenses for non-traditional foodservice operations under the trade names “Noble Roman’s Pizza,” “Noble Roman’s Take-n-Bake,” and “Tuscano’s Italian Style Subs.” The company has awarded franchise and/or license agreements in all 50 states plus Washington, D.C., Puerto Rico, the Bahamas, Italy, Canada and the Dominican Republic.

The statements contained in this press release concerning the company’s future revenues, profitability, financial resources, market demand and product development are forward-looking statements (as such term is defined in the Private Securities Litigation Reform Act of 1995) relating to the company that are based on the beliefs of the management of the company, as well as assumptions and estimates made by and information currently available to the company’s management. The company’s actual results in the future may differ materially from those projected in the forward-looking statements due to risks and uncertainties that exist in the company’s operations and business environment, including, but not limited to, competitive factors and pricing pressures, non-renewal of franchise agreements, shifts in market demand, the success of new franchise programs with limited operating history including the stand-alone take-n-bake locations, general economic conditions, changes in purchases of or demand for the company’s products, licenses or franchises, the success or failure of individual franchisees and licensees, changes in prices or supplies of food ingredients and labor, and dependence on continued involvement of current management. Should one or more of these risks or uncertainties materialize, or should underlying assumptions or estimates prove incorrect, actual results may differ materially from those described herein as anticipated, believed, estimated, expected or intended. The company undertakes no obligations to update the information in this press release for subsequent events.

FOR ADDITIONAL INFORMATION, CONTACT:

For Media Information:

Scott Mobley
President & CEO
317/634-3377

For Investor Relations:

Paul Mobley
Executive Chairman
317/634-3377

Brett Maas
Hayden IR,
646/536-7331
brett@haydenir.com

SOURCE: Noble Roman’s, Inc.

ReleaseID: 430128

CORAL GABLES, FL / ACCESSWIRE / June 25, 2015 / The U.S economy slightly fell in the first quarter of 2015 as it had a hard time with bad weather, a strong dollar, spending cuts in the energy sector and interruptions at West Coast ports. However in the second quarter the economy is showing growth and has rebounded thus far. A rebounding economy can equate to an uptrend in “Blue Chip” stocks, as more investors are willing to invest money in a bullish market. This growth also has ignited movement in small cap companies such as Soligenix, Inc. (OTCQB: SNGX), FBEC Worldwide Inc. (PINKSHEETS: FBEC) and Dominovas Energy Corp. (OTCQB: DNRG).

Soligenix, Inc. is a late-stage biotech company that owns the intellectual property, preclinical and clinical data for SGX301, a novel orphan drug treated for cutaneous T-cell lymphoma. The company recently announced that SGX301 would initiate phase III trials with the help of the National Organization for Rare Disorders (NORD) and the Cutaneous Lymphoma Foundation (CLF). Over the last 5 days Soligenix, price per share has surged 95% from a low of $1.51 to a new 52 week high of $2.95 Wednesday after the news was released. Soligenix price target that was set by Zacks Small Cap Research is $5.50 per share and the stock is currently priced at $2.53.

FBEC Worldwide Inc. offers consumers their signature H.E.M.P infused energy shot. The cannabis space is valued at 3.1 billion dollars according to TheStreet.com. Since May, FBEC has made key announcements that have been the driving force for the increase in stock price from lows of $0.02 to highs of $0.12 in June. One announcement they made was the distribution deal with J&D Labs to manufacture hemp infused nutraceuticals. J&D Labs has over 25 years of experience and a team of 300 experienced members ranging from pharmacists, microbiologists, engineers and chemists. FBEC is currently trading between $0.08-$0.10.

Dominovas Energy Corp. is an energy company that offers an off-grid RUBICON Solid Oxide Fuel Cell system announced an historic partnership with the U.S government. The fuel cell system has been named the first, and only fuel cell Company chosen as a Private Sector Partner to President Barack Obama’s POWER AFRICA INITIATIVE. Over the last 2 days Dominovas Energy Corp. has seen an impressive run opening June 23rd at $0.0052 and seeing a price increase spiking 1,601% to a high of $0.0885 on June 24th. Earlier in June Dominovas entered into a second power provider agreement in the Democratic Republic of the Congo as well as signing a multi-megawatt agreement.

ABOUT US:

www.DailyStockReporter.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals www.DailyStockReporter.com is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading Penny Stocks. You can subscribe to the www.DailyStockReporter.com newsletter and start receiving daily alerts. To subscribe by phone and receive messages directly to a mobile phone, text the phrase “StockAlerts” to 63566.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements.

EGM FIRM INC which owns www.DailyStockReporter.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release.
EGM FIRM INC, which owns www.DailyStockReporter.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice.

EGM FIRM INC which owns www.DailyStockReporter.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.

CONTACT:

Company: EGM FIRM INC.
Contact Email: adam@egmfirm.com

SOURCE: DailyStockReporter.com

ReleaseID: 430151

SAN ANTONIO, TX / ACCESSWIRE / June 25, 2015 / Wytec International, Inc., a subsidiary of Competitive Companies Inc. (CCI) (PINKSHEETS: CCOP), announced today it has developed an electronic marketing system called “WyQuote” allowing independent direct sales agents access to instantaneous online quotes to nationwide wireless services available to their clients. “We are very excited about this development and its immense capabilities in “ramping up” substantial revenues for both CCI and on Wytec’s Diamond Ring backhaul,” remarks William Gray, President/CEO. The WyQuote marketing system was conceived when the Company began focusing on how to generate usage on its millimeter wave network.

After extensive research, the Company discovered that more than 60% of U.S. telecom sales are generated through an online quote system. “There are three major quoting platforms in the U.S. utilized by approximately 100,000 direct and master agents generating over 2,500,000 instant quotes for products and services for their clients every month,” remarks Michael Adzija, Network Operations Manager.

Capaciti Networks, a wholly owned subsidiary of CCI, will manage the initial online activation of the WyQuote system. Upon activation, Capaciti expects to open the portal to more than 40,000 U.S. direct telecom agents introducing both fixed and mobile broadband services. The WyQuote system will host wireless services only and will not host “wired” services such as DSL, Cable or Fiber Optic Internet access. It is the only online electronic quote system on the market today to focus entirely on wireless products and services. Wytec will earn a monthly fee from both enterprise sales and data usage for the use of WyQuote.

About Wytec International, Inc.

Wytec, a subsidiary of Competitive Companies, Inc., was founded in 2011 as a Nevada-based corporation with corporate offices in San Antonio, Texas. The Company’s primary business focus is developing next generation fixed and mobile wireless broadband technologies in support of the upcoming 5th Generation (5G) Networks designed to expand the current 4G LTE Networks. 5G Networks are aimed to support a minimum of one (1) gigabit of data transfer to fixed and mobile wireless end users utilizing a variety of hand-held smart devices such as smartphones, laptops and tablets. It is also designed to be the primary network in support of the growing Machine to Machine (M2M) applications and other high speed services included in the upcoming “Internet of Things” mobile data marketplace.

About Capaciti Networks, Inc.

Capaciti Networks, Inc., (CNI) a wholly owned subsidiary of CCI, was founded by CCI as a marketing company to market and sell the parent Company’s products and services. After discovering that more than 60% of all telecom sales in the U.S. are generated through an electronic online portal, CNI began researching opportunities to utilize this valuable sales resource. When determining that none of the online portals provided efficient electronic quotes for wireless services, CCI began working with a platform quote provider to custom design its own totally wireless version of a marketing quote system. This evolved into WyQuote and will be utilized by Capaciti Networks in its products and service offerings to master and direct sales agents throughout the U.S. For more information about Capaciti Networks and on how to become a direct sales agent, go to www.capacitinetworks.com.

Forward-Looking Statements

This press release contains statements that are “forward-looking” and are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995 and federal securities laws. Generally, the words “expect,” “intend,” “estimate,” “will” and similar expressions identify forward-looking statements. Since forward-looking statements address future conditions, they involve inherent risks and uncertainties. Actual results in each case could differ materially from those currently anticipated in such statements. Investors are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date they are made.

CONTACT:

Erica Perez
Media Relations
Email eperez@cci-us.com
Website www.cci-us.com

SOURCE: Competitive Companies Inc.

ReleaseID: 430132

WESTON, FL / ACCESSWIRE / June 25, 2015 / Next 1 Interactive, Inc. (Next 1) (OTCQB: NXOI) (OTCQB: NXOID), announced today that it has completed its name change and structuring to become Monaker Group, Inc. (“Monaker”). This is one of the final steps towards beginning expanded growth. For the next twenty one days the company will trade under the stock symbol NXOID signifying that there has been a 50 for 1 share exchange, thereafter the trading symbol will be MKGI (OTCQB: MKGI).

Monaker has emerged as a digital media marketing company focusing on lifestyle enrichment for consumers in the travel, home and employment sectors. At the core of its marketing services are key elements including proprietary video-centered technology and established partnerships currently being leveraged to enhance reach.

Video is quickly becoming consumer’s preferred method of searching and educating themselves prior to purchases. Monaker’s video creation technology and film libraries combine to create lifestyle video offerings that can be shared through trusted distribution systems of its major partners. The end result is better engagement with consumers who gain in-depth information on related products and services helping to both inform and fulfill purchases. Unlike traditional marketing companies that simply charge for advertising creation, Monaker holds licenses and/or expertise in the travel, real estate and employment sectors allowing it to capture fees at the point of purchase while the majority of transactions are handled by Monaker’s partners. This should allow the company to capture greater revenues while eliminating much of the typical overhead associated with fulfillment.

Monaker has core holdings in each of its key areas:

– Travel – Maupintour Extraordinary Vacations, NextTrip.com, Stingy Travel and Voyage.TV
– Home – www.HomeAndAwayClub.com and 35% ownership of RealBiz Media Group, Inc. (OTCQB: RBIZ)
– Employment – 51% ownership in www.NameYourFee.com

Additionally, the company is continually expanding strategic partnerships and is already working with some of the largest partners in their respective industries including:

– I.C.E., Inc. (key membership rewards company with 55 million members, handling loyalty fulfillment for several Fortune 500 companies)
– Jasper Group, Inc. (employment specialist with over 6000 recruiting partners)
– Launch 360 Media, Inc. (operates R&R Television Network into 34 million North American Homes)

The Company expects product and revenue growth through its partner’s customer base utilizing its digital platforms and by developing specialized mobile apps for both the travel and employment sectors. Monaker will also utilize its reach through R&R TV (with currently 34 million households in their network) to heighten awareness of current and new offerings. Monaker Group – through its ownership in Maupintour, NameYourFee.com and RealBiz Media Group, Inc. will assist consumers at home, work and play.

About Monaker Group:

Monaker Group, Inc. (“Monaker”) is a digital media marketing company focusing on lifestyle enrichment for consumers in the travel, home and employment sectors. Core to its marketing services are key elements including proprietary video-centered technology and established partnerships that enhance its reach. Video is quickly becoming consumer’s preferred method of searching and educating themselves prior to purchases. Monaker’s video creation technology and film libraries combine to create lifestyle video offerings that can be shared both to its customers and through trusted distribution systems of its major partners. The end result is better engagement with consumers who gain in-depth information on related products and services helping to both inform and fulfill purchases. Unlike traditional marketing companies that simply charge for advertising creation, Monaker holds licenses and/or expertise in the travel, real estate and employment sectors allowing it to capture fees at the point of purchase while the majority of transactions are handled by Monaker’s partners. This should allow the company to capture greater revenues while eliminating much of the typical overhead associated with fulfillment. Monaker core holdings include Maupintour, NameYourFee.com, RealBiz Media Group – helping it to deliver marketing solutions to consumers at home, work and play.

Safe Harbor Statement:

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plan, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks described in statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements that may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

CONTACT:

Chesapeake Group
Kevin Holmes
info@chesapeakegp.com
+1 (410) 825-3930

SOURCE: Next 1 Interactive, Inc.

ReleaseID: 430133